ArticleAdvanced healthcare materials2026
3D-Printed Porous Titanium Alloy Scaffolds Incorporated With Tetramethylpyrazine-Loaded Composite Hydrogels Enhance Angiogenesis and Bone Repair for Femoral Head Osteonecrosis.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Osteonecrosis of the femoral head (ONFH) is a debilitating condition caused by compromised local blood supply to the femoral head, which leads to bone tissue death. The primary therapeutic goals are to restore blood perfusion and reconstruct the damaged bone structure. In this study, we present an advanced three dimensional printed multifunctional composite scaffold that integrates structural biomimicry, sustained drug release, and microenvironment regulation to enable the sequentially coordinated augmentation of ONFH repair. The scaffold features Voronoi-designed porous titanium alloy biomimetic trabeculae that provide robust mechanical support, combined with a gelatin methacryloyl and silk fibroin hydrogel-liposome dual-release system. This design ensures mechanical stability, bioactive functionality, and sustained delivery of tetramethylpyrazine. In vitro assessments demonstrate its excellent biocompatibility, promoting osteogenic differentiation and angiogenic tube formation. In vivo studies using a rat ONFH model reveal significantly increased new bone volume and density, accompanied by enhanced angiogenesis and bone repair. Thus, this scaffold presents a promising strategy for the early treatment of hip-preserving ONFH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.